Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Hodges Equity Income Retail (HDPEX)

Net Asset Value
1 Day
Overall Morningstar Rating
Large value
Style or Category
No Load
Sales Expenses
Expense Ratio
Below Average
Morningstar Risk Rating™
Investment Objective The investment seeks income and long-term capital appreciation. The fund invests at least 80% of its net assets (plus any borrowings for investment purposes) in income producing equity securities. While the Fund invests primarily in securities that are traded in the United States, it may also invest up to 25% of its net assets in stocks of foreign companies which are U.S. dollar denominated and trade on a domestic national securities exchange (including American Depositary Receipts, European Depositary Receipts and Global Depositary Receipts), debt securities of companies, debt obligations of governments and their agencies and other similar securities.


1 month+0.41% 3 years+10.01%
3 months+10.21% 5 years+10.01%
1 year-0.82% Since inception+10.97%
Data through --

Peer Comparisonvs. Large value

Performance 5-yr return+10.01%+10.79%
Expense ratio1.47%1.12%
Risk 5 year sharpe ratio0.940.96
Net assets$16.6M$2.2B
Average market cap$48.6B$81.6B
Average P/E17.117.3
Portfolio turnover43%43%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyHodges
Fund manager & tenureCraig Hodges / 6 Years
Minimal initial investment$1,000.00
Minimum IRA investment$1,000.00


U.S. stock97.78%
International stock0.00%
Fixed income0.00%
Top 5 Sectors
Portfolio weighting
Energy 17.65%
Consumer goods 15.60%
Utilities 12.30%
Telecommunication 11.14%
Hardware 10.64%
Top 10 Holdings
Portfolio weighting
BA Boeing6.70%
HD Home Depot6.65%
CBRL Cracker Barrel Old Country Store Inc5.65%
MSFT Microsoft5.38%
JNJ Johnson & Johnson4.48%
GEO Geo Group Inc4.28%
CALM Cal-Maine Foods Inc4.19%
ABBV AbbVie4.18%
GILD Gilead Sciences3.77%
CNK Cinemark Holdings Inc3.53%